Steroid-sparing regimens in organ transplantation

Dean Y. Kim, Mark D Stegall

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Although corticosteroids have been a mainstay of immunosuppressive regimens for decades, their use has been associated with significant morbidity in transplant recipients. Several studies in liver transplant recipients suggest that steroid-sparing regimens are well tolerated immunologically and may reduce cardiovascular complications associated with their use. The safety and efficacy of steroid withdrawal in kidney, pancreas, and heart transplants are less clear. With the introduction of newer, potent immunosuppressive agents such as tacrolimus, mycophenolate mofetil, and sirolimus, steroid withdrawal is being tested more frequently in these organs. Recent data in clinical pancreatic islet transplantation even suggest that corticosteroids may be contraindicated in this type of transplant. This review covers the recent progress made in steroid-sparing regimens and some of the current controversies in islet and solid organ transplantation.

Original languageEnglish (US)
Pages (from-to)313-319
Number of pages7
JournalCurrent Opinion in Organ Transplantation
Volume6
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Organ Transplantation
Steroids
Immunosuppressive Agents
Adrenal Cortex Hormones
Mycophenolic Acid
Transplants
Islets of Langerhans Transplantation
Tacrolimus
Sirolimus
Pancreas
Morbidity
Kidney
Safety
Liver
Transplant Recipients

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Steroid-sparing regimens in organ transplantation. / Kim, Dean Y.; Stegall, Mark D.

In: Current Opinion in Organ Transplantation, Vol. 6, No. 4, 2001, p. 313-319.

Research output: Contribution to journalArticle

@article{0af516b3413d44c2a1d5ffeb9b6b9de6,
title = "Steroid-sparing regimens in organ transplantation",
abstract = "Although corticosteroids have been a mainstay of immunosuppressive regimens for decades, their use has been associated with significant morbidity in transplant recipients. Several studies in liver transplant recipients suggest that steroid-sparing regimens are well tolerated immunologically and may reduce cardiovascular complications associated with their use. The safety and efficacy of steroid withdrawal in kidney, pancreas, and heart transplants are less clear. With the introduction of newer, potent immunosuppressive agents such as tacrolimus, mycophenolate mofetil, and sirolimus, steroid withdrawal is being tested more frequently in these organs. Recent data in clinical pancreatic islet transplantation even suggest that corticosteroids may be contraindicated in this type of transplant. This review covers the recent progress made in steroid-sparing regimens and some of the current controversies in islet and solid organ transplantation.",
author = "Kim, {Dean Y.} and Stegall, {Mark D}",
year = "2001",
doi = "10.1097/00075200-200112000-00008",
language = "English (US)",
volume = "6",
pages = "313--319",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Steroid-sparing regimens in organ transplantation

AU - Kim, Dean Y.

AU - Stegall, Mark D

PY - 2001

Y1 - 2001

N2 - Although corticosteroids have been a mainstay of immunosuppressive regimens for decades, their use has been associated with significant morbidity in transplant recipients. Several studies in liver transplant recipients suggest that steroid-sparing regimens are well tolerated immunologically and may reduce cardiovascular complications associated with their use. The safety and efficacy of steroid withdrawal in kidney, pancreas, and heart transplants are less clear. With the introduction of newer, potent immunosuppressive agents such as tacrolimus, mycophenolate mofetil, and sirolimus, steroid withdrawal is being tested more frequently in these organs. Recent data in clinical pancreatic islet transplantation even suggest that corticosteroids may be contraindicated in this type of transplant. This review covers the recent progress made in steroid-sparing regimens and some of the current controversies in islet and solid organ transplantation.

AB - Although corticosteroids have been a mainstay of immunosuppressive regimens for decades, their use has been associated with significant morbidity in transplant recipients. Several studies in liver transplant recipients suggest that steroid-sparing regimens are well tolerated immunologically and may reduce cardiovascular complications associated with their use. The safety and efficacy of steroid withdrawal in kidney, pancreas, and heart transplants are less clear. With the introduction of newer, potent immunosuppressive agents such as tacrolimus, mycophenolate mofetil, and sirolimus, steroid withdrawal is being tested more frequently in these organs. Recent data in clinical pancreatic islet transplantation even suggest that corticosteroids may be contraindicated in this type of transplant. This review covers the recent progress made in steroid-sparing regimens and some of the current controversies in islet and solid organ transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0035686978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035686978&partnerID=8YFLogxK

U2 - 10.1097/00075200-200112000-00008

DO - 10.1097/00075200-200112000-00008

M3 - Article

VL - 6

SP - 313

EP - 319

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 4

ER -